Study on Telemonitoring App for Adults with Heart Failure Using Digital Tools to Track Blood Pressure and Weight

What this Trial Is About

Researchers are studying the impacts of telemedicine, specifically telemonitoring, on patients with heart failure. This randomized, non-pharmacological study aims to identify both the positive effects co-creation and negative effects co-destruction associated with telemonitoring services for this patient group. The study is led by Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico. Participants diagnosed with chronic heart failure are randomly assigned to one of two groups. Those in the experimental group download a telemonitoring app to regularly enter their blood pressure and body weight, which is reviewed by the hospital team through a platform. The control group continues with standard care without using the app. Both groups complete questionnaires at enrollment and at follow-up visits scheduled at three and six months. During the study, participants provide their health data through the app if in the experimental group, and all participants complete questionnaires to assess various health and experience dimensions. The main outcome measured is the Patient Activation Measure PAM13-I at six months. The study includes safety monitoring and follows participants over a total of six months to evaluate the telemonitoring services effects on heart failure management.

EVOLVING AZIMUTH IN MUSA CONTEXT